These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 15665656

  • 1. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA, Okumuş B, Osmanagaoglu T, Bozkaya H.
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [Abstract] [Full Text] [Related]

  • 2. Association between serum cholesterol and bone mineral density.
    Makovey J, Chen JS, Hayward C, Williams FM, Sambrook PN.
    Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
    [Abstract] [Full Text] [Related]

  • 3. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women.
    Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan PF, Liao EY.
    Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886
    [Abstract] [Full Text] [Related]

  • 4. Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea.
    Jeong IK, Cho SW, Kim SW, Choi HJ, Park KS, Kim SY, Lee HK, Cho SH, Oh BH, Shin CS.
    Calcif Tissue Int; 2010 Dec; 87(6):507-12. PubMed ID: 20976443
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy.
    Song EK, Yeom JH, Shin HT, Kim SH, Shin WG, Oh JM.
    J Clin Pharm Ther; 2006 Oct; 31(5):421-7. PubMed ID: 16958819
    [Abstract] [Full Text] [Related]

  • 6. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505
    [Abstract] [Full Text] [Related]

  • 7. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP, Liao EY, Wu XP, Cao XZ, Shan PF, Su X.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):371-5. PubMed ID: 16677543
    [Abstract] [Full Text] [Related]

  • 8. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 14; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 9. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
    Sumino H, Ichikawa S, Kasama S, Takahashi T, Sakamoto H, Kumakura H, Takayama Y, Kanda T, Murakami M, Kurabayashi M.
    Hypertens Res; 2008 Jun 14; 31(6):1191-7. PubMed ID: 18716368
    [Abstract] [Full Text] [Related]

  • 10. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
    Zofkova I, Hill M.
    Endocr Regul; 2008 Sep 14; 42(4):121-7. PubMed ID: 18999899
    [Abstract] [Full Text] [Related]

  • 11. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO, Choi JT, Choi HA, Moon IG, Yim CH, Park WK, Yoon HK, Han IK.
    Clin Endocrinol (Oxf); 2005 Mar 14; 62(3):349-53. PubMed ID: 15730418
    [Abstract] [Full Text] [Related]

  • 12. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep 14; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 13. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy.
    Murano T, Izumi S, Kika G, Haque SF, Okuwaki S, Mori A, Suzuki T, Matsubayashi H, Ikeda M, Goya K, Makino T.
    Tokai J Exp Clin Med; 2003 Oct 14; 28(3):109-19. PubMed ID: 15055403
    [Abstract] [Full Text] [Related]

  • 14. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.
    Brownbill RA, Ilich JZ.
    J Womens Health (Larchmt); 2006 Apr 14; 15(3):261-70. PubMed ID: 16620185
    [Abstract] [Full Text] [Related]

  • 15. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.
    Menopause; 2009 Apr 14; 16(5):950-5. PubMed ID: 19387415
    [Abstract] [Full Text] [Related]

  • 16. Body fat distribution is associated with lumbar spine bone density independently of body weight in postmenopausal women.
    Saarelainen J, Honkanen R, Kröger H, Tuppurainen M, Jurvelin JS, Niskanen L.
    Maturitas; 2011 May 14; 69(1):86-90. PubMed ID: 21388758
    [Abstract] [Full Text] [Related]

  • 17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 May 14; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 18. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S, Fiegenbaum M, de Andrade FM, Osório-Wender MC, Hutz MH.
    Maturitas; 2006 May 20; 54(2):119-26. PubMed ID: 16242874
    [Abstract] [Full Text] [Related]

  • 19. The effect of circulating androgens on bone mineral density in postmenopausal women.
    Tok EC, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S.
    Maturitas; 2004 Jul 15; 48(3):235-42. PubMed ID: 15207889
    [Abstract] [Full Text] [Related]

  • 20. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
    Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML.
    Menopause; 2006 Jul 15; 13(3):451-61. PubMed ID: 16735942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.